Aromatase Inhibitors in Breast Cancer: An Overview-Reference-Cited by-同舟云学术

Aromatase Inhibitors in Breast Cancer: An Overview

Published:2006-06-01 Issue:6 Volume:11 Page:553-562
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Altundag Kadri¹²,Ibrahim Nuhad K.²

Affiliation:

1. a Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA

2. b Department of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey

Abstract

Learning Objectives After completing this course, the reader will be able to: Discuss the published data on aromatase inhibitors in breast cancer.Describe the differences in study designs, clinical outcome, and safety data on aromatase inhibitors.Select the proper aromatase inhibitor based on a thorough understanding of the data that led to the specific indication for the drug. Access and take the CME test online and receive 1 AMA PRA category 1 credit at CME.TheOncologist.com

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.11-6-553

Reference48 articles.

1. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases;Beatson;Lancet,1896

2. Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years;Love;Arch Intern Med,1994

3. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Early Breast Cancer Trialists' Collaborative Group (EBCTCG);Lancet,2005

4. Overview of the main outcomes in breast-cancer prevention trials;Cuzick;Lancet,2003

5. Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial;Fisher;J Natl Cancer Inst,2001

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Steatotic liver disease in metastatic breast cancer treated with endocrine therapy and CDK4/6 inhibitor;2024-08-18

2. ESR1 Gene Mutations and Liquid Biopsy in ER-Positive Breast Cancers: A Small Step Forward, a Giant Leap for Personalization of Endocrine Therapy?;Cancers;2023-10-27

3. In-silico and in-vitro study reveals ziprasidone as a potential aromatase inhibitor against breast carcinoma;Scientific Reports;2023-10-02

4. In Silico Mixed Ligand/Structure-Based Design of New CDK-1/PARP-1 Dual Inhibitors as Anti-Breast Cancer Agents;International Journal of Molecular Sciences;2023-09-06

5. Estrogens and the risk of breast cancer: A narrative review of literature;Heliyon;2023-09